NCT00976248
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Waldenstrom Macroglobulinemia. Study availability and eligibility vary by location and protocol.
NCT00976248
NCT01273766
NCT00416312
NCT01789255
NCT02071888
NCT00119392
NCT01129193
NCT01567709
NCT00398710
NCT01805375